Ocular abnormalities in chronic schizophrenia: clinical implications

References

• Walsh FB, Hoyt WF. Clinical neuro-ophthalmology., 3rd ed. Williams & Wilkins, Baltimore 1969
   Google Scholar
• Scheie HG, Albert DM. Textbook of ophthalmology., 9th ed. Saunders, Philadelphia 1977
   Google Scholar
• Grant WM, Schuman JS. Toxicology of the eye., 4th ed. Charles C. Thomas, Illinois 1993
   Google Scholar
• Mathalone M BR. Eye and skin changes in psychiatric patients treated with chlorpromazine. British Journal of Ophthalmology 1967; 51: 86–93
   PubMed Web of Science ®Google Scholar
• DeLong SL. Incidence and significance of chlorpromazine eye changes. Diseases of the Nervous System 1968; 29(Suppl.)19–22
   Google Scholar
• Baron JB, Morel P, Rivoalan Y, Foulairac A. Ocular side effects of prolonged treatment with chlorpromazine associated or not with skin complications. Agressologie 1968; 9: 293–304
   PubMedGoogle Scholar
• Baron JB, Morel P, Rivoalan Y. Long term evolution of the lens opacities induced by chlorpromazine prolonged therapy. Agressologie 1971; 12: 57–60
   PubMedGoogle Scholar
• Boet DJ. Toxic effects of phenothiazines in the eye. Documenta Ophthalmologica 1970; 28: 1–69
   PubMed Web of Science ®Google Scholar
• Kalberer M, Atar Z, Bider E. On eye changes in long-term treatment with largactil. Ophthalmologica 1970; 161: 118–124
   PubMed Web of Science ®Google Scholar
• Mason CG. Ocular accumulation and toxicity of certain systemically administered drugs. Journal of Toxicology and Environmental Health 1977; 2: 977–995
   PubMed Web of Science ®Google Scholar
• Gerhard J, Franck H, Sommer S, Mack G. Ophthalmologic side effects of treatment with phenothiazines. Revue d'Oto-Neuro-Ophthalmologie 1975; 47: 71–77
   PubMedGoogle Scholar
• Issac NE, Walker AM, Jick H, Gorman M. Exposure to phenothiazine drugs and risk of cataract. Archives of Ophthalmology 1991; 109: 256–260
   PubMedGoogle Scholar
• Deluise V, Flynn JT. Asymmetric anterior segment changes induced by chlorpromazine. Annals of Ophthalmology 1981; 13: 953–955
   PubMed Web of Science ®Google Scholar
• Howard RO, McDonald CJ, Dunn B, Creasey WA. Experimental chlorpromazine cataracts. Investigative Ophthalmology 1969; 8: 412–421
   Google Scholar
• Baum JL. The effect of chloroquine, chlorpromazine and ultraviolet radiation on the corneas of pigmented rabbits. Acta Ophthalmologica 1972; 50: 18–25
   Web of Science ®Google Scholar
• Mitchell AC, Brown KW. Chlorpromazine-induced retinopathy. British Journal of Psychiatry 1995; 166: 822–823
   PubMed Web of Science ®Google Scholar
• Zelickson AS, Zeller HC. A new and unusual reaction to chlorpromazine. Journal of the American Medical Association 1964; 188: 394–396
   PubMed Web of Science ®Google Scholar
• Henkes HE. Fenothiazine-retinopathy. Nederlands Tijdschrift voor Geneeskunde 1966; 110: 789–790
   PubMedGoogle Scholar
• Siddall JR. Ocular toxic changes associated with chlorpromazine and thioridazine. Canadian Journal of Ophthalmology 1966; 1: 190–198
   PubMedGoogle Scholar
• Siddall JR. Ocular complications related to phenothiazines. Diseases of the Nervous System 1968; 29(Suppl.)10–13
   Google Scholar
• Nouri A, Ceundet JF. Ocular side effects in the course of prolonged treatment with neuroleptics. Schweizerische Medizinische Wochenschrift 1968; 98: 1708–1711
   PubMedGoogle Scholar
• Petrohelos MA, Tricoulis D. Ocular complications of chlorpromazine therapy. Ophthalmologica 1969; 159: 31–38
   PubMed Web of Science ®Google Scholar
• Segal RL, Rosenblatt S, Eliasoph I. Endocrine exophthalmos during lithium therapy of manic-depressive disease. New England Journal of Medicine 1973; 289: 136–138
   PubMed Web of Science ®Google Scholar
• Saul RF, Hamburger HA, Selhorst JB. Pseudotumor cerebri secondary to lithium carbonate. Journal of the American Medical Association 1985; 253: 2869–2870
   PubMed Web of Science ®Google Scholar
• Bourgeois JA. Ocular side effects of lithium—a review. Journal of the American Optometric Association 1991; 62: 548–551
   PubMedGoogle Scholar
• O'Farrell TJ, Connors GJ, Upper D. Addictive behaviours among hospitalised psychiatric patients. Addictive Behaviours 1983; 8: 329–333
   PubMed Web of Science ®Google Scholar
• The Eye Disease Case-Control Study Group. Risk factors for neo-vascular age-related macular degeneration. Archives of Ophthalmology 1992; 110: 1701–1708
   PubMed Web of Science ®Google Scholar
• Prummel MF, Wiersinga WM. Smoking and risk of Graves disease. Journal of the American Medical Association 1993; 269: 479–482
   PubMed Web of Science ®Google Scholar
• Westermeyer J. A third case of self-enucleation. American Journal of Psychiatry 1972; 129: 144
   Web of Science ®Google Scholar
• Rosen DH, Hoffman AM. Focal suicide: self-enucleation by two young psychotic individuals. American Journal of Psychiatry 1972; 128: 123–128
   Web of Science ®Google Scholar
• MacLean G, Robertson BM. Self-enucleation and psychosis. Archives of General Psychiatry 1976; 33: 242–249
   PubMed Web of Science ®Google Scholar
• Tapper CM, Bland RC, Danyluk L. Self-inflicted eye injuries and self-inflicted blindness. Journal of Nervous and Mental Disease 1979; 167: 311–314
   PubMed Web of Science ®Google Scholar
• Ananth J, Kaplan HS, Lin K. Self-inflicted enucleation of an eye: two case reports. Canadian Journal of Psychiatry 1984; 29: 145–146
   PubMed Web of Science ®Google Scholar
• Clark RA. Self-mutilation accompanying religious delusions: a case report and review. Journal of Clinical Psychiatry 1981; 42: 243–244
   PubMed Web of Science ®Google Scholar
• Jones NP. Self-enucleation and psychosis. British Journal of Ophthalmology 1990; 74: 571–573
   PubMed Web of Science ®Google Scholar
• Nelson HE, Pantelis C, Carruthers K, Speller J, Baxendale S, Barnes T RE. Cognitive functioning and symptomatology in chronic schizophrenia. Psychological Medicine 1990; 20: 357–365
   PubMed Web of Science ®Google Scholar
• Lieberman AA, Coburn AF. The health of the chronically mentally ill: a review of the literature. Community Mental Health Journal 1986; 22: 104–116
   PubMed Web of Science ®Google Scholar
• Farmer S. Medical problems of chronic patients in a community support program. Hospital and Community Psychiatry 1987; 38: 745–749
   PubMedGoogle Scholar
• Schwab B, Drake RE, Burghardt E. Health care of the chronically mentally ill: the culture broker model. Community Mental Health Journal 1988; 24: 174–184
   PubMed Web of Science ®Google Scholar
• Allodi F, Cohen M. Physical illness and length of psychiatric hospitalisation. Canadian Psychiatric Association Journal 1978; 23: 101–106
   PubMedGoogle Scholar
• Koranyi EK. Morbidity and rate of undiagnosed physical illnesses in a psychiatric clinic population. Archives of General Psychiatry 1979; 36: 414–419
   PubMed Web of Science ®Google Scholar
• Tessler RC, Manderscheid RW. Factors affecting adjustment to community living. Hospital and Community Psychiatry 1982; 33: 203–207
   PubMedGoogle Scholar